Survey conducted among early breast cancer patients treated with Arimidex for evaluation of treatment adherence - ARIADNE
Study identifier:NIS-OHU-ARI-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Survey and follow-up of the treatment adherence and medication habits of early breast cancer patients on adjuvant hormonal therapy with the aromatase inhibitor Arimidex
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
1077
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Mar 2010
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Zsolt Horvath
Hungarian National Institute of Oncology
